Quarterly report pursuant to Section 13 or 15(d)

Other Income / (Expense) - Narrative (Details)

v3.22.2.2
Other Income / (Expense) - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Gain on sale of Investments $ 11,682 $ 0
CCXI [Member]    
Gain on sale of Investments 37,200  
Changzhou Eminence Biotechnology [Member]    
Gain on sale of Investments $ 11,700